Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.
Journal: Circulation. Cardiovascular interventions
Published: February 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.
Journal: Circulation. Cardiovascular interventions
Published: February 27, 2026
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.
Journal: Journal of the American Heart Association
Published: October 23, 2025
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial.
Journal: JACC. Cardiovascular interventions
Published: December 18, 2024
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
Journal: Journal of the American Heart Association
Published: April 02, 2024
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD.
Journal: Vascular medicine (London, England)
Published: March 17, 2024
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.
Journal: Circulation
Published: February 20, 2024
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization.
Journal: Journal of the American College of Cardiology
Published: January 17, 2024
Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Journal: American journal of hypertension
Published: November 09, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Journal: Circulation
Published: October 18, 2023
Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: June 02, 2023
Last Updated: 09/26/2026